NCT05097248 2021-10-28Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of ChemotherapyUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2 Unknown52 enrolled